HBsAg Decline After Pegylated-interferon-α in e Antigen Positive Chronic Hepatitis B With Nucleoside Maintenance

NCT01769833 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

144

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: PEG-interferon-Alfa-2A
DRUG: Nucleosides

Sponsor

Pusan National University Hospital